Posted Foot-High Stacks Cash Fueled a $2.8M Check Fraud
A flashy Instagram post showing posted foot-high stacks cash can lure people into a risky and illegal scheme. This ar...
Which To Choose For Retirement Index Vs Target Date
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
24,517 articles
Ethereum’s 2026 Roadmap Just Signals Long-Term Shift Ahead
Ethereum released its 2026 roadmap, outlining three tracks for Scale, Improve UX, and Harden L1. Analysts say ETH won...
Bitcoin Resurgence Sends BTC Price Outlook Higher Today
Bitcoin resumes strength amid a broader risk-off backdrop for gold. The bitcoin resurgence faces a critical test near...
What Know About This Fund's $65 Million Homebuilder Bet Before a $47-Per-Share Buyout
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
280% YTD, Will AMD’s Rally Continue in 2026?
AMD has ridden a steep year-to-date surge powered by AI and cloud demand. Analysts warn the rally faces hurdles, but ...
Joby Aviation Stock Surging: Signals Risk and Opportunity
Joby Aviation stock surging has a few clear triggers: progress on electric air mobility, a strategic partnership with...
Maestro Supports Robinhood Chain: Lightning-Fast Trading Bot
Maestro has gone live on Robinhood Chain, bringing its Telegram-first trading bot to a fast-moving Arbitrum layer-2. ...
Fund Dumps $6.5 Million SentinelOne Stake Amid Stock Slide
A prominent investor dumped $6.5 million of SentinelOne stock as the cybersecurity firm’s shares fell sharply. This a...
Is 2026 the Moment to Buy OCCIDENTAL PETROLEUM Stock?
Occidental Petroleum surges in 2026 on debt cleanup after the OxyChem sale, with oil prices supportive but questions ...
Oberndorf William Dumps 74,000 Shares: What It Signals
A major hedge fund exit grabbed headlines as a fund controlled by William Oberndorf liquidated a sizable monday.com s...
Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Oil Upside Risks Persist as OPEC+ Adds Supply, Kevin Book Says
Oil prices have cooled, yet a veteran observer warns that upside risks could re-emerge. OPEC+ supply increases, Hormu...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status